Insulin receptor tyrosine kinase beta subunit (IR β-subunit)

The insulin receptor tyrosine kinase beta subunit is one half of the dimeric transmembrane protein complex known as the insulin receptor. The full mature human insulin receptor consists structurally of two extracellular α-subunits responsible for ligand binding and two membrane-spanning intracellular β-subunits that possess intrinsic tyrosine kinase activity. Upon binding by its primary ligand—insulin—the α-chains transmit conformational changes that activate autophosphorylation within conserved motifs on each cytoplasmic β-chain. This phosphorylation event triggers recruitment/phosphorylation cascades involving IRS proteins among others, ultimately regulating cellular glucose uptake, metabolism, growth signals, gene expression changes, lipid synthesis/storage pathways—and more broadly orchestrating systemic energy homeostasis. Dysfunctional IRβ signaling underlies major pathologies including type 2 diabetes mellitus (via reduced sensitivity), rare congenital syndromes with severe resistance due to mutations/polymorphisms affecting this domain’s function or expression level—and has been implicated in certain cancers where aberrant activation may drive proliferation/survival pathways.

Other names

Insulin receptor β-subunitIRβINSR β-chain

Drugs targeting this molecule typically act by mimicking endogenous insulin to activate the receptor’s intrinsic tyrosine kinase activity. This leads to autophosphorylation of key tyrosines on the β-subunit, recruitment/phosphorylation of IRS proteins, and initiation of downstream metabolic effects such as increased glucose uptake.